TLX1 translocation variants and enhancer hijacking influence clinical outcome in T‐cell acute lymphoblastic leukemia

Documenti analoghi

• Neo‐enhancers in T‐cell acute lymphoblastic Leukaemia (T‐ ALL ) and beyond
  di: Charlotte Smith, et al.
  Pubblicazione: (2025)
• Biological Findings and Clinical Outcomes in Patients Treated With R‐CHOP Plus High‐Dose Methotrexate as First‐Line Therapy in Large B‐Cell Lymphoma With Testis Involvement
  di: R. Liévin, et al.
  Pubblicazione: (2024)
• The 12th International Tooling Conference & Exhibition, TOOLING 2022
  di: Nader Asnafi
  Pubblicazione: (2024)
• DNA methylation as a new tool for the differential diagnosis between T‐LBL and lymphocyte‐rich thymoma
  di: Mehdi Latiri, et al.
  Pubblicazione: (2024)
• An Efficient Algorithm for Permutation Iteration Using a Singly Linked List
  di: Baruchel, Thomas
  Pubblicazione: (2025)